Alpha 2.0
Login Register
» Articles » PMID: 26721981

INFECTIOUS DISEASE. As Ebola Epidemic Draws to a Close, a Thin Scientific Harvest

Overview
Journal Science
Specialty Science
Date 2016 Jan 2
PMID 26721981
Citations 11
Authors
Jon Cohen
Martin Enserink
Affiliations
Soon will be listed here.
Citing Articles

Completion and reporting of COVID-19 clinical trials registered on ClinicalTrials.gov during the first 6 months of the pandemic: cohort study.

Tornhammar P, Julner A, Al Moosawi N, Wicksell E, Lim C, Andersson D BMJ Open. 2024; 14(11):e085906.

PMID: 39542470 PMC: 11575289. DOI: 10.1136/bmjopen-2024-085906.

The Past Need Not Be Prologue: Recommendations for Testing and Positioning the Most-Promising Medical Countermeasures for the Next Outbreak of Ebola Virus Infection.

Davey Jr R, Dodd L, Proschan M, Jahrling P, Hensley L, Higgs E J Infect Dis. 2018; 218(suppl_5):S690-S697.

PMID: 30032267 PMC: 6249585. DOI: 10.1093/infdis/jiy334.

What treating Ebola means for pandemic influenza.

Fedson D J Public Health Policy. 2018; 39(3):268-282.

PMID: 30013135 PMC: 7102163. DOI: 10.1057/s41271-018-0138-8.

Rigorous Clinical Trial Design in Public Health Emergencies Is Essential.

Ellenberg S, Keusch G, Babiker A, Edwards K, Lewis R, Lundgren J Clin Infect Dis. 2017; 66(9):1467-1469.

PMID: 29177461 PMC: 5905619. DOI: 10.1093/cid/cix1032.

Interferon-β and Interferon-γ Are Weak Inhibitors of Ebola Virus in Cell-Based Assays.

Dyall J, Hart B, Postnikova E, Cong Y, Zhou H, Gerhardt D J Infect Dis. 2017; 215(9):1416-1420.

PMID: 28368541 PMC: 5853567. DOI: 10.1093/infdis/jix134.